Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.

Parra RS, Chebli JMF, Amarante HMBS, Flores C, Parente JML, Ramos O, Fernandes M, Rocha JJR, Feitosa MR, Feres O, Scotton AS, Nones RB, Lima MM, Zaltman C, Goncalves CD, Guimaraes IM, Santana GO, Sassaki LY, Hossne RS, Bafutto M, Junior RLK, Faria MAG, Miszputen SJ, Gomes TNF, Catapani WR, Faria AA, Souza SCS, Caratin RF, Senra JT, Ferrari MLA.

World J Gastroenterol. 2019 Oct 14;25(38):5862-5882. doi: 10.3748/wjg.v25.i38.5862.

2.

PHYSICAL ACTIVITY IN DAILY LIFE, EXERCISE CAPACITY AND QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE ON INFLIXIMAB-INDUCED REMISSION: A PRELIMINARY STUDY.

Cabalzar AL, Azevedo FM, Lucca FA, Reboredo MM, Malaguti C, Chebli JMF.

Arq Gastroenterol. 2019 Oct 14. pii: S0004-28032019005003102. doi: 10.1590/S0004-2803.201900000-65. [Epub ahead of print]

3.

Case Report: Treatment for Rectovaginal Fistula in Crohn's Disease Using Fractionate CO2 Vaginal Laser with Anti-TNF Therapy.

Drumond DG, Chebli JMF, Speck NMG, Chebli LA, Pannain GD, Esperança SD, Condé CMS.

Photobiomodul Photomed Laser Surg. 2019 Jul;37(7):451-454. doi: 10.1089/photob.2019.4643. Epub 2019 Jun 17.

PMID:
31210577
4.

Ulcerative colitis - treatment with biologicals.

Teixeira FV, Vilela EG, Damião AOMC, Vieira A, Albuquerque IC, Parente JML, Chebli JMF, Ambrogini Junior O, Hossne RS, Miszputen SJ.

Rev Assoc Med Bras (1992). 2019 May 2;65(4):547-553. doi: 10.1590/1806-9282.65.4.547.

5.

The Impact of Spirituality and Religiosity on Mental Health and Quality of Life of Patients with Active Crohn's Disease.

de Campos RJDS, Lucchetti G, Lucchetti ALG, da Rocha Ribeiro TC, Chebli LA, Malaguti C, Gaburri PD, Pereira LMN, de Almeida JG, Chebli JMF.

J Relig Health. 2019 Mar 25. doi: 10.1007/s10943-019-00801-1. [Epub ahead of print]

PMID:
30911874
6.

Limp and Fever Leading to a Surprising Diagnosis.

Chebli LA, Gaburri PD, Chebli JMF.

Am J Med. 2019 Jun;132(6):704-705. doi: 10.1016/j.amjmed.2019.01.034. Epub 2019 Mar 2. No abstract available.

PMID:
30831064
7.

Infectious diarrhea in autologous stem cell transplantation: high prevalence of coccidia in a South American center.

Castro MD, Chebli JM, Costa LJ, Alves KRL, Atalla A, Neto AEH.

Hematol Transfus Cell Ther. 2018 Apr-Jun;40(2):132-135. doi: 10.1016/j.htct.2017.10.002. Epub 2018 Feb 17.

8.

Impact of superimposed Clostridium difficile infection in Crohn's or ulcerative colitis flares in the outpatient setting.

Garcia PG, Chebli LA, da Rocha Ribeiro TC, Gaburri PD, de Lima Pace FH, Barbosa KVBD, Costa LA, de Almeida Cruz W, de Assis IC, Moraes BRM, Zanini A, Chebli JMF.

Int J Colorectal Dis. 2018 Sep;33(9):1285-1294. doi: 10.1007/s00384-018-3105-8. Epub 2018 Jun 21.

PMID:
29926235
9.

An Unusual Cause of Skin Rash in Crohn's Disease.

Chebli JMF, de Oliveira Moreira B, da Rocha Ribeiro TC.

Gastroenterology. 2018 Sep;155(3):618-620. doi: 10.1053/j.gastro.2018.01.061. Epub 2018 Aug 4. No abstract available.

PMID:
29409941
10.

Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ.

Agholme L, Clarin M, Gkanatsiou E, Kettunen P, Chebli J, Brinkmalm G, Blennow K, Bergström P, Portelius E, Zetterberg H.

Mol Cell Neurosci. 2017 Dec;85:211-219. doi: 10.1016/j.mcn.2017.10.009. Epub 2017 Nov 8.

PMID:
29104140
11.

Impact of biological therapy on body composition of patients with Chron's disease.

Santos JCD, Malaguti C, Lucca FA, Cabalzar AL, Ribeiro TCDR, Gaburri PD, Chebli LA, Chebli JMF.

Rev Assoc Med Bras (1992). 2017 May;63(5):407-413. doi: 10.1590/1806-9282.63.05.407.

12.

Severe hypoproteinemia as a harbinger of Ménétrier's disease in autoimmune pancreatitis.

Chebli JMF, Chebli LA, Ribeiro TCDR, Gaburri PD.

Rev Assoc Med Bras (1992). 2017 Mar;63(3):215-218. doi: 10.1590/1806-9282.63.03.215.

13.

Physical Exercise Programmes in Patients With Inflammatory Bowel Disease.

Reboredo MM, Pinheiro BV, Chebli JMF.

J Crohns Colitis. 2017 Oct 1;11(10):1286. doi: 10.1093/ecco-jcc/jjx037. No abstract available.

PMID:
28369347
14.

Small-Intestinal Bacterial Overgrowth is Associated With Concurrent Intestinal Inflammation But Not With Systemic Inflammation in Crohn's Disease Patients.

Ricci JER Júnior, Chebli LA, Ribeiro TCDR, Castro ACS, Gaburri PD, Pace FHDL, Barbosa KVBD, Ferreira LEVVDC, Passos MDCF, Malaguti C, Delgado ÁHDA, Campos JD, Coelho AR, Chebli JMF.

J Clin Gastroenterol. 2018 Jul;52(6):530-536. doi: 10.1097/MCG.0000000000000803.

PMID:
28134633
15.

Severe Malabsorption Refractory to Pancreatic Enzyme Supplementation Unmasking Autoimmune Enteropathy in a Chronic Pancreatitis Patient.

Chebli JM, Chebli LA, Gaburri PD, de Almeida Delgado ÁA, Costa TM.

Pancreas. 2016 Sep;45(8):e43-4. doi: 10.1097/MPA.0000000000000611. No abstract available.

PMID:
27518366
16.

Internet-Based Interventions for Addictive Behaviours: A Systematic Review.

Chebli JL, Blaszczynski A, Gainsbury SM.

J Gambl Stud. 2016 Dec;32(4):1279-1304. Review.

PMID:
27002522
17.

Endothelial and Epithelial Cell Transition to a Mesenchymal Phenotype Was Delineated by Nestin Expression.

Chabot A, Hertig V, Boscher E, Nguyen QT, Boivin B, Chebli J, Bissonnette L, Villeneuve L, Brochiero E, Dupuis J, Calderone A.

J Cell Physiol. 2016 Jul;231(7):1601-10. doi: 10.1002/jcp.25257. Epub 2015 Dec 2.

PMID:
26574905
18.

Complementary roles of KCa3.1 channels and β1-integrin during alveolar epithelial repair.

Girault A, Chebli J, Privé A, Trinh NT, Maillé E, Grygorczyk R, Brochiero E.

Respir Res. 2015 Sep 4;16:100. doi: 10.1186/s12931-015-0263-x.

19.

Physical Activity in Hemodialysis Patients Measured by Triaxial Accelerometer.

Gomes EP, Reboredo MM, Carvalho EV, Teixeira DR, Carvalho LF, Filho GF, de Oliveira JC, Sanders-Pinheiro H, Chebli JM, de Paula RB, Pinheiro Bdo V.

Biomed Res Int. 2015;2015:645645. doi: 10.1155/2015/645645. Epub 2015 May 24.

20.

Intestinal spirochetosis: an unusual cause of IBD flare-up during anti-TNF therapy.

Chebli JM, de Abreu NC, Chebli LA, Reboredo MM, Pinheiro HS.

Int J Colorectal Dis. 2016 Mar;31(3):745-6. doi: 10.1007/s00384-015-2240-8. Epub 2015 May 16. No abstract available.

PMID:
25982466
21.

Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology.

Antunes CV, Hallack Neto AE, Nascimento CR, Chebli LA, Moutinho IL, Pinheiro Bdo V, Reboredo MM, Malaguti C, Castro AC, Chebli JM.

Biomed Res Int. 2015;2015:728925. doi: 10.1155/2015/728925. Epub 2015 Feb 1.

22.

Hypertransaminasemia following withdrawal of thiopurine therapy in an ulcerative colitis patient: mind looking the small bowel!

Chebli JM, Reboredo MM, Pinheiro HS, Pinheiro Bdo V.

Int J Colorectal Dis. 2015 Dec;30(12):1737-8. doi: 10.1007/s00384-015-2149-2. Epub 2015 Feb 10. No abstract available.

PMID:
25665517
23.

Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.

Vidigal FM, de Souza GS, Chebli LA, da Rocha Ribeiro TC, Furtado MC, Castro AC, Pinto AL, do Valle Pinheiro B, de Lima Pace FH, Machado de Oliveira J, de Oliveira Zanini KA, Gaburri PD, Zanini A, Ribeiro LC, Chebli JM.

Med Sci Monit. 2014 Nov 5;20:2165-70. doi: 10.12659/MSM.890975.

24.

Gouverneur's syndrome in a patient with abdominal pain: mind Crohn's disease!

Chebli JM, Figueiredo AA, Gaburri PD.

Rev Assoc Med Bras (1992). 2014 May-Jun;60(3):196-7. No abstract available.

25.

Positive correlation between disease activity index and matrix metalloproteinases activity in a rat model of colitis.

Oliveira LG, Cunha AL, Duarte AC, Castañon MC, Chebli JM, Aguiar JA.

Arq Gastroenterol. 2014 Apr-Jun;51(2):107-12.

26.

[Conglomerate silicosis in a sandblasting worker].

Pinheiro Bdo V, Reboredo Mde M, Chebli JM, de Oliveira JC.

Med Clin (Barc). 2014 Sep 9;143(5):238. doi: 10.1016/j.medcli.2014.04.005. Epub 2014 Jun 5. Spanish. No abstract available.

PMID:
24908622
27.

Hepatitis and pneumonitis during adalimumab therapy in Crohn disease: mind the histoplasmosis!

Pinheiro Bdo V, Delgado Ade A, Chebli JM.

Arq Gastroenterol. 2014 Jan-Mar;51(1):73-6.

28.

A guide to prepare patients with inflammatory bowel diseases for anti-TNF-α therapy.

Chebli JM, Gaburri PD, Chebli LA, da Rocha Ribeiro TC, Pinto AL, Ambrogini Júnior O, Damião AO.

Med Sci Monit. 2014 Mar 26;20:487-98. doi: 10.12659/MSM.890331. Review.

29.

Effect of azathioprine or mesalazine therapy on incidence of re-hospitalization in sub-occlusive ileocecal Crohn's disease patients.

de Souza GS, Vidigal FM, Chebli LA, da Rocha Ribeiro TC, Furtado MC, de Lima Pace FH, de Miranda Chaves LD, de Oliveira Zanini KA, Gaburri PD, de Azevedo Lucca F, Zanini A, Ribeiro LC, Chebli JM.

Med Sci Monit. 2013 Aug 30;19:716-22. doi: 10.12659/MSM.889196.

30.

Acute diarrhea in hospitalized children of the municipality of Juiz de Fora, MG, Brazil: prevalence and risk factors associated with disease severity.

Rocha MC, Carminate DL, Tibiriçá SH, Carvalho IP, Silva ML, Chebli JM.

Arq Gastroenterol. 2012 Dec;49(4):259-65.

31.

Mood swings in patients with Crohn's disease: incidence and associated factors.

Lima FD, Ribeiro TC, Chebli LA, Pace FH, Chaves LD, Ribeiro MS, Chebli JM.

Rev Assoc Med Bras (1992). 2012 Jul-Aug;58(4):481-8. English, Portuguese.

32.

The results of a surgical complication protection program (BLIS, Inc.) for private pay bariatric patients in the U.S.: 2006-2011.

Chebli JE, Schindler R.

Obes Surg. 2012 Nov;22(11):1798-801. doi: 10.1007/s11695-012-0745-6.

PMID:
22911150
33.

Oral refeeding in mild acute pancreatitis: an old challenge.

Chebli JM, Gaburri PD, Chebli LA.

World J Gastrointest Pathophysiol. 2011 Dec 15;2(6):100-2. doi: 10.4291/wjgp.v2.i6.100.

34.

Insulin resistance in non-diabetic patients with chronic hepatitis C: what does it mean?

Souza AF, Pace FH, Chebli JM, Ferreira LE.

Arq Bras Endocrinol Metabol. 2011 Aug;55(6):412-8.

PMID:
22011858
35.

[Infection by hepatitis C virus in patients on hemodialysis: prevalence and risk factors].

Leão JR, Pace FH, Chebli JM.

Arq Gastroenterol. 2010 Jan-Mar;47(1):28-34. Portuguese.

36.

Early onset steroid-dependent ulcerative colitis is a predictor of azathioprine response: a longitudinal 12-month follow-up study.

Chebli LA, Felga GG, Chaves LD, Pimentel FF, Guerra DM, Gaburri PD, Zanini A, Chebli JM.

Med Sci Monit. 2010 Feb;16(2):PI1-6.

PMID:
20110928
37.

A full solid diet as the initial meal in mild acute pancreatitis is safe and result in a shorter length of hospitalization: results from a prospective, randomized, controlled, double-blind clinical trial.

Moraes JM, Felga GE, Chebli LA, Franco MB, Gomes CA, Gaburri PD, Zanini A, Chebli JM.

J Clin Gastroenterol. 2010 Aug;44(7):517-22. doi: 10.1097/MCG.0b013e3181c986b3.

PMID:
20054282
38.

[Non-adherence to the therapy in Crohn's disease patients: prevalence and risk factors].

Cornélio Rde C, Pinto AL, Pace FH, Moraes JP, Chebli JM.

Arq Gastroenterol. 2009 Jul-Sep;46(3):183-9. Portuguese.

39.

Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis.

Chebli LA, Chaves LD, Pimentel FF, Guerra DM, Barros RM, Gaburri PD, Zanini A, Chebli JM.

Inflamm Bowel Dis. 2010 Apr;16(4):613-9. doi: 10.1002/ibd.21083.

PMID:
19705415
40.

Psychological distress in Brazilian Crohn's disease patients: screening, prevalence, and risk factors.

Brandi MT, Ribeiro MS, Chebli LA, Franco MB, Pinto AL, Gaburri PD, Zanini A, Chebli JM.

Med Sci Monit. 2009 Aug;15(8):PH101-8.

PMID:
19644430
41.

Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.

Pinto AL, Chebli LA, Ribeiro MS, Pace FH, Moraes JP, do Amaral FJ Jr, Gaburri PD, Meirelles de Souza AF, Chebli JM.

Med Sci Monit. 2009 May;15(5):PI19-26.

PMID:
19396048
42.

Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?

Ribeiro TC, Chebli JM, Kondo M, Gaburri PD, Chebli LA, Feldner AC.

Ther Clin Risk Manag. 2008 Oct;4(5):919-25.

43.

[Azathioprine toxicity in Crohn's disease: incidence, approach and course].

Colli MV, Amaro TA, Pinto AL, Gaburri PD, Chebli JM.

Rev Assoc Med Bras (1992). 2008 Sep-Oct;54(5):415-21. Portuguese.

44.

[Nosocomial diarrhea in the intensive care unit: incidence and risk factors].

Borges SL, Pinheiro Bdo V, Pace FH, Chebli JM.

Arq Gastroenterol. 2008 Apr-Jun;45(2):117-23. Portuguese.

45.

Onychomycosis in inflammatory bowel diseases.

Gaburri D, Chebli JM, Zanine A, Gamonal AC, Gaburri PD.

J Eur Acad Dermatol Venereol. 2008 Jul;22(7):807-12. doi: 10.1111/j.1468-3083.2008.02588.x. Epub 2008 Apr 24.

PMID:
18435735
46.

An unusual cause of extrahepatic cholestasis.

Gaburri PD, Souza GS, Chebli JM.

Clin Gastroenterol Hepatol. 2008 Feb;6(2):e7-8. doi: 10.1016/j.cgh.2007.11.015. Epub 2008 Jan 9. No abstract available.

PMID:
18187368
47.

Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.

Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.

J Gastroenterol Hepatol. 2007 Feb;22(2):268-74.

PMID:
17295882
48.

Education and imaging. Gastrointestinal: Whipple's disease.

Coli MV, Chebli JM, Gaburri PD.

J Gastroenterol Hepatol. 2007 Jan;22(1):136. No abstract available.

PMID:
17201897
49.

Choledocholithiasis.

Chebli JM, Gaburri PD, Morais JM.

Lancet. 2005 Aug 27-Sep 2;366(9487):748. No abstract available.

PMID:
16125593
50.

Oral refeeding in patients with mild acute pancreatitis: prevalence and risk factors of relapsing abdominal pain.

Chebli JM, Gaburri PD, De Souza AF, Junior EV, Gaburri AK, Felga GE, De Paula EA, Forn CG, De Almeida GV, De Castro Nehme F.

J Gastroenterol Hepatol. 2005 Sep;20(9):1385-9.

PMID:
16105125

Supplemental Content

Loading ...
Support Center